<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Nephrol</journal-id><journal-title>Pediatric Nephrology (Berlin, Germany)</journal-title><issn pub-type="ppub">0931-041X</issn><issn pub-type="epub">1432-198X</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18535843</article-id><article-id pub-id-type="pmc">2644745</article-id><article-id pub-id-type="publisher-id">856</article-id><article-id pub-id-type="doi">10.1007/s00467-008-0856-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Salt restriction in kidney disease&#x02014;a missed therapeutic opportunity?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ritz</surname><given-names>Eberhard</given-names></name><address><email>prof.e.ritz@t-online.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mehls</surname><given-names>Otto</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Department of Internal Medicine, Ruperto Carola University of Heidelberg, Nierenzentrum, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany </aff><aff id="Aff2"><label>2</label>Division of Pediatric Nephrology, University Children&#x02019;s Hospital of Heidelberg, Heidelberg, Germany </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>6</month><year>2008</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2009</year></pub-date><volume>24</volume><issue>1</issue><fpage>9</fpage><lpage>17</lpage><history><date date-type="received"><day>8</day><month>1</month><year>2008</year></date><date date-type="rev-recd"><day>9</day><month>4</month><year>2008</year></date><date date-type="accepted"><day>10</day><month>4</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; IPNA 2008</copyright-statement></permissions><abstract><p>The importance of salt restriction in the treatment of patients with renal disease has remained highly controversial. In the following we marshal the current evidence that salt plays a definite role in the genesis of hypertension and target organ damage, point to practical problems of salt restriction, and report on novel pathomechanisms of how salt affects blood pressure and causes target organ damage.</p></abstract><kwd-group><title>Keywords</title><kwd>Chronic kidney disease (CKD)</kwd><kwd>Salt intake</kwd><kwd>Salt restriction</kwd><kwd>Programming of blood pressure</kwd><kwd>Hypertension</kwd><kwd>Target organ damage</kwd><kwd>Cardiotonic steroids</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; IPNA 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1"><title>Salt and blood pressure</title><sec id="Sec2"><title>Adults</title><p>In a crucial experiment, Denton et al. [<xref ref-type="bibr" rid="CR1">1</xref>] measured the blood pressure of chimpanzees on a salt-enriched diet and control chimpanzees on a no-added salt diet. After 6&#x000a0;months in chimpanzees on a salt enriched diet blood pressure had increased in chimpanzees on a salt-enriched diet, from 110&#x000a0;mmHg systolic to 145&#x000a0;mmHg, while it had not changed in the control group. The effect was fully reversible after the high salt diet was stopped. Meanwhile, the Dietary Approaches to Stop Hypertension (DASH) study provided convincing evidence that a diet with reduced salt (NaCl) intake [but also additional dietary manipulation, particularly higher potassium (K) intake] decreased systolic blood pressure: when sodium (Na) intake was reduced from 150&#x000a0;mmol/day to 50&#x000a0;mmol/day, systolic blood pressure (office blood pressure) decreased by 6.7&#x000a0;mmHg in the overall cohort, and, in hypertensive individuals, even by 11&#x000a0;mmHg [<xref ref-type="bibr" rid="CR2">2</xref>]. This may even have been an underestimate. Using the more sensitive ambulatory blood pressure measurement, a double-blind placebo-controlled crossover trial recently showed that reduction of salt intake by 50&#x000a0;mmol/day from 150&#x000a0;mmol/day to 100&#x000a0;mmol/day lowered 24&#x000a0;h blood pressure by no less than 5.7&#x000a0;mmHg systolic and by 6.3&#x000a0;mmHg at night time [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p>The change in blood pressure with salt restriction is particularly marked in patients with renal failure [<xref ref-type="bibr" rid="CR4">4</xref>], and this parallels the observation of an exaggerated blood pressure increase in animals on a high salt intake that was characterized by reduced numbers of nephrons [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec><sec id="Sec3"><title>Children, programming and salt sensitivity of blood pressure</title><p>More than 20 observational studies on salt and blood pressure in children were reviewed by Simons-Morton and Obarzanek in 1997 [<xref ref-type="bibr" rid="CR6">6</xref>]. The majority of studies showed a significant positive association between salt intake and blood pressure. In the study by Cooper and Liu [<xref ref-type="bibr" rid="CR7">7</xref>] a significant linear relationship between urinary sodium and blood pressure in 73 children aged 11&#x000a0;years to 14&#x000a0;years was noticed after the authors had controlled for age, gender, race, pulse rate, height and body weight. The same result was noticed in 233 Dutch children aged 5&#x000a0;years to 17&#x000a0;years and followed up for &#x02265;&#x02009;7&#x000a0;years [<xref ref-type="bibr" rid="CR8">8</xref>]. A meta-analysis of ten controlled trials with 966 children and adolescents was reported by He and MacGregor [<xref ref-type="bibr" rid="CR9">9</xref>]. Mean salt intake was reduced by 42%, and the median duration was 4&#x000a0;weeks, ranging from 2&#x000a0;weeks to 3&#x000a0;years. Both systolic (&#x02212;1.17&#x000a0;mmHg) and diastolic (&#x02212;1.29&#x000a0;mmHg) blood pressures were significantly decreased. In three trials on infants, including 541 participants, salt intake was reduced by 54% and the systolic blood pressure by 2.47&#x000a0;mm Hg. The authors concluded that neonatal salt intake may induce blood pressure tracking and late hypertension.</p><p>Many experimental studies have documented that the fetal environment, including salt intake of mothers, can have long-lasting effects on blood pressure, but salt intake was not studied as an independent factor.</p><p>Exposure of mothers to low or high salt throughout gestation had a long-lasting impact on salt preference of offspring [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. In the study by Ross et al. lambs were exposed to in utero hypernatremia induced by maternal water restriction [<xref ref-type="bibr" rid="CR12">12</xref>]. Offspring of prenatally water-restricted mothers exhibited hypernatremia, hypertonicity and hypertension. Thus, maternal nutrient stress may program altered osmoregulation and systemic arterial hypertension in the offspring. Interestingly, Crystal and Bernstein [<xref ref-type="bibr" rid="CR13">13</xref>] demonstrated that infants of mothers who had suffered morning sickness during early pregnancy drank more concentrated salt solutions than controls. In young students whose mothers reported morning sickness, M&#x000e1;laga et al. also found a greater preference for salty food [<xref ref-type="bibr" rid="CR14">14</xref>]. In infants and young children, salt taste preference was inversely related to birth weight over the first 4&#x000a0;years of life [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p>Thus, the early response to salty tasting food might predict future sodium intake and blood pressure.</p><p>Porter et al. [<xref ref-type="bibr" rid="CR16">16</xref>] were the first to investigate whether high salt intake in the mother programmed blood pressure and heart rate hyper-responsiveness to stress in adult offspring independently of birth weight. A high sodium diet administered to pregnant rats during the perinatal period was not sufficient to program lasting hypertension (measured by telemetry) or salt sensitivity of blood pressure in offspring. However, enhanced pressure and tachycardiac response to acute stress persisted into adulthood. This was accompanied by increased mRNA expression of corticotrophin-releasing hormone under basal and stress conditions. The programmed defects did not depend on birth weight and might have involved other mechanisms, for instance augmented activation of the sympathetic nervous system.</p><p>According to the Borst&#x02013;Gyton concept, chronic hypertension occurs only with a shift in the renal pressure&#x02013;natriuresis relationship, resulting in increased salt sensitivity of blood pressure. Birth weight was negatively associated with salt sensitivity of blood pressure, and this was independent of the association between birth weight and glomerular filtration rate (GFR) [<xref ref-type="bibr" rid="CR17">17</xref>]. Kidney and central nervous system seem to be the major sites for salt sensing: by chloride sensing in renal tubule fluids via sodium&#x02013;potassium&#x02013;chloride (Na-K-Cl) co-transporter isoforms in the macula densa cells; by sodium sensing in cerebrospinal fluid; by the sensing of cerebrospinal fluid osmolarity by mechanosensitive, non-selected cation channels, and by osmolarity sensing in glial cells [<xref ref-type="bibr" rid="CR18">18</xref>]. The plurality of salt-sensing mechanisms allows very precise control of blood pressure. Modifications of sensor programming or of feedback signaling are strong candidates for the programming of blood pressure and salt sensitivity. Other options for the development of salt-sensitive hypertension are genetic and congenital factors, which might predispose individuals to microvascular disease; interstitial damage; local angiotensin II formation, and oxidant generation [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec4"><title>Effects of salt intake on cardiovascular and other endpoints</title><p>Apart from the effect of salt intake on blood pressure, its effect on cardiovascular endpoints is of interest as well. A recent meta-analysis showed by extrapolation that, in the general population, reduction of salt intake by 3&#x000a0;g/day, and the resulting decrease in blood pressure, would translate into a 13% reduction in stroke and a 10% reduction in ischemic heart disease events [<xref ref-type="bibr" rid="CR9">9</xref>]. An observational study from Finland even suggested that a 100&#x000a0;mmol difference in salt intake would reduce the relative risk of coronary heart disease by 50%, independent of blood pressure [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p>Apart from these observational studies, there is only one series of two small prospective but long-term (10&#x02013;15&#x000a0;years) studies available in which salt intake was reduced by 44&#x000a0;mmol/day and 33&#x000a0;mmol/day, respectively. These Trials of Hypertension Prevention (TOPH) I and TOPH II studies document a significant impact of moderate salt reduction on cardiovascular endpoints by 25%. There was even a trend for reduction of mortality by 20% [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p>Apart from the information on cardiovascular events, limited information is also available on the effect of high salt intake on renal parameters. Salt load increases the local concentration of angiotensin II in the kidney, thus constricting the efferent vessels of the glomeruli followed by an increase in intraglomerular pressure and filtration [<xref ref-type="bibr" rid="CR19">19</xref>]. Verhave et al. [<xref ref-type="bibr" rid="CR22">22</xref>] observed that urine albumin excretion in the general population was correlated with the magnitude of sodium excretion; this correlation was most marked in individuals in the highest tertile of the body mass index. A correlation between salt intake and albuminuria has also been found in the rat uninephrectomy model [<xref ref-type="bibr" rid="CR23">23</xref>] and in the Munich Wistar rat with spontaneously reduced nephron numbers [<xref ref-type="bibr" rid="CR5">5</xref>]. Albumin excretion rates were also higher in rats with intra-uterine growth retardation [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p>Of considerable interest are observations on the effect of salt intake in rats with renal injury. Dworkin et al. [<xref ref-type="bibr" rid="CR25">25</xref>] kept subtotally nephrectomized rats for 4&#x000a0;weeks on standard chow and subsequently randomly allocated them either to low salt chow or standard chow. A reduction in proteinuria was observed in the rats on the low-salt chow and progression in rats on standard chow; this was accompanied by a further increase in the proportion of sclerotic glomeruli in the latter group.</p><p>Salt loading also promotes renal fibrosis in numerous, but not all, models of renal damage [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Of particular interest is the observation that the effect of salt restriction cannot be reproduced by the administration of a diuretic [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec></sec><sec id="Sec5"><title>Mechanisms of salt-induced target organ damage</title><p>In patients with chronic kidney disease a high salt intake may be &#x0201c;nephrotoxic&#x0201d; by indirect mechanisms, e.g. by an increase in blood pressure and by attenuation of the pharmacologic blockade of the renin&#x02013;angiotensin system blunting its anti-hypertensive and anti-proteinuric effect. The latter was elegantly documented when patients with nephrotic proteinuria were treated with lisinopril: the anti-proteinuric effect was markedly reduced by a high-salt diet [<xref ref-type="bibr" rid="CR29">29</xref>]. In patients with chronic kidney disease, salt loading increases renovascular resistance, with the attendant decrease in renal plasma flow, and increases glomerular capillary pressure as extrapolated from the increase in filtration fraction [<xref ref-type="bibr" rid="CR30">30</xref>], effects certainly undesirable in patients with chronic kidney disease.</p><p>One main pathomechanism underlying salt-induced tissue damage is oxidative stress, a phylogenetically ancient reaction: when plants, such as marigold, grow in an environment with high salinity, oxidative stress occurs and leads to stunted growth [<xref ref-type="bibr" rid="CR31">31</xref>]. Similarly, high salt intake increases oxidative stress in the mammalian kidney by a combination of increased generation and decreased breakdown of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="CR32">32</xref>]: the expression of reduced nicotinamide adenine dinucleotide phosphate [NADPH] oxidase mRNA is increased 2&#x02013;3 fold, whilst the expression of several isoforms of superoxide dismutase is reduced. Increased oxidative stress in the animals on high-salt diets is proven by the decreased urinary excretion of 8-isoprostane, a lipid marker of oxidative stress [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p>High salt intake presumably causes hypervolemia, increases blood flow and shear stress in central arterial vessels and induces expression of endothelial nitric oxide (NO) synthase (eNOS) [<xref ref-type="bibr" rid="CR33">33</xref>]. In the kidney as well, Sato et al. [<xref ref-type="bibr" rid="CR34">34</xref>] documented that expression of eNOS mRNA is modulated by salt intake. In the Thy1 glomerulonephritis model this was paralleled by changes in the expression of transforming growth factor beta (TGF-&#x003b2;) [<xref ref-type="bibr" rid="CR35">35</xref>].</p></sec><sec id="Sec6"><title>The right balance between too little and too much salt</title><p>Currently there is an animated discussion as to whether reduction of salt intake might have negative consequences. It goes without saying that radical salt restriction causes hypovolemia, with the attendant adverse effects, e.g. reduced resistance against circulatory shock and possibly also predisposition to acute renal failure. Extremely low salt intake also causes more long-term adverse effects, such as acceleration of atherosclerosis, as shown in a genetic model of atherosclerosis, the apoE&#x02212;/&#x02212;mouse [<xref ref-type="bibr" rid="CR36">36</xref>]: a low-salt diet stimulated the renin&#x02013;angiotensin system and increased the size of atherosclerotic plaques in the aorta. It is also of interest that, in pregnant rats, an extremely low salt intake (0.03%) causes intrauterine growth restriction and adult hypertension in the offspring [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>The explanation of why both too high and too low a salt intake cause adverse effects is the fact that high salt intake induces inhibitors of the Na<sup>+</sup>K<sup>+</sup> pump (cardiotonic steroids) on the one hand [<xref ref-type="bibr" rid="CR38">38</xref>], whilst low salt intake up-regulates the activity of the renin&#x02013;angiotensin system, increases angiotensin II, and up-regulates NADPH oxidase, thus generating reactive oxidant species [<xref ref-type="bibr" rid="CR39">39</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Both too high and too low a salt intake produce ROS and oxidative end products</p></caption><graphic position="anchor" xlink:href="467_2008_856_Fig1_HTML" id="MO1"/></fig></p><p>A sound balance between these two extremes is struck by current guidelines [<xref ref-type="bibr" rid="CR40">40</xref>], which recommend for adults a reduction in the usual daily sodium intake to 80&#x02013;100&#x000a0;mmol, corresponding to an intake of 4.7&#x02013;5.8&#x000a0;g salt.</p></sec><sec id="Sec7"><title>What evidence is available in children?</title><p>In children, two controlled trials were performed in free-living individuals in whom urinary sodium output was measured. Children with a mean age of 11&#x000a0;years had a mean intake of 133&#x000a0;mmol sodium per day (7.8&#x000a0;g salt) [<xref ref-type="bibr" rid="CR41">41</xref>]. In 13-year-old boys the mean intake was 150&#x000a0;mmol per day, and in girls it was 142&#x000a0;mmol per day (corresponding to 8.8&#x000a0;g and 8.4&#x000a0;g salt, respectively) [<xref ref-type="bibr" rid="CR42">42</xref>]. In 4&#x02013;6&#x000a0;year-old children the average urinary sodium was 64&#x000a0;mmol per day, corresponding to 3.8&#x000a0;g salt [<xref ref-type="bibr" rid="CR43">43</xref>]. The National Diet and Nutrition Survey for young people, which was carried out in Great Britain in 1997, investigated 1,658 participants aged between 4&#x000a0;years and 18&#x000a0;years regarding their salt intake and blood pressure. The mean salt intake was 4.7&#x000a0;g/day at the age of 4&#x000a0;years, and it increased with age to 6.8&#x000a0;g/day at the age of 18&#x000a0;years. After adjustment for age, gender, body mass index and dietary potassium, an increase of 1&#x000a0;g salt per day was related to an increase of 0.4&#x000a0;mmHg systolic pressure and 0.6&#x000a0;mmHg pulse pressure [<xref ref-type="bibr" rid="CR44">44</xref>]. In children the proportion of food that children consumed in restaurants and food outlets increased by 300% between 1977 and 1996 [<xref ref-type="bibr" rid="CR45">45</xref>]. In the Finish Special Turku Coronary Risk Factor Intervention Project (STRIP), children had exceeded the estimated requirements of the US National Academy of Science by about 700% at 13&#x000a0;months, 3&#x000a0;years and 5&#x000a0;years of age [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p>For children no data exist on the physiological ranges required for sodium homeostasis. Therefore, the recommendations for sodium intake in infants are based on the upper end of the breast milk reference intake range, whereas, for older children, the recommendations are estimated factorially by calculation of daily increments in total body sodium content, allowing for changing body composition and compartmentation, such as the declining proportion with age of extracellular fluid in body mass and for dermal, fecal and some urinary losses. According to the dietary recommendations of the Scientific Advisory Committee on Nutrition, the estimated minimum requirements of sodium for 1-year-old children is 225&#x000a0;mg sodium/day (0.6&#x000a0;g NaCl), and for 2&#x02013;5&#x000a0;year-old children it is 300&#x000a0;mg/day (0.8&#x000a0;g NaCl) [<xref ref-type="bibr" rid="CR47">47</xref>]. The British reference nutrient intakes (RNIs) for sodium and target average salt intake are given in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.These values have been estimated on the same basis used to derive the recommended target salt intake for adults, i.e. an increase in the RNI by a factor of 1.5. There is insufficient evidence to define precisely the upper limits of salt intake in relation to cardiovascular risk in children.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Reference nutrient intakes (RNIs) for sodium and target average salt intake for infants and children</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Age (years)</th><th colspan="2">RNI</th><th rowspan="2">Target average intake (g/day)</th></tr><tr><th>Sodium mmol/day (mg/day)</th><th>salt (g/day)</th></tr></thead><tbody><tr><td>0&#x02013;0.5</td><td>8 (184)</td><td>0.5</td><td>&#x0003c; 1</td></tr><tr><td>0.5&#x02013;1</td><td>12 (276)</td><td>0.7</td><td>1</td></tr><tr><td>1&#x02013;6</td><td>26 (598)</td><td>1.6</td><td>2</td></tr><tr><td>7&#x02013;14</td><td>60 (1,380)</td><td>3.6</td><td>5</td></tr></tbody></table></table-wrap></p><p>An unresolved issue remains about how patients can manage to achieve reduction of their salt intake from the current 12&#x02013;14&#x000a0;g/day for adults to the above recommended level. Unfortunately, according to Sanchez-Castillo [<xref ref-type="bibr" rid="CR48">48</xref>], table salt contributes only 10% to the daily dietary intake, and no more than 5% is contributed by salt added during cooking&#x02014;both sources can be directly controlled by patients. In contrast, 85% of salt is latent, added by the food industry and therefore contained in the food items used for cooking. As a result, the recommended moderate reduction of salt intake is difficult to achieve. The best strategy is a community approach involving health policy actions to motivate the food industry to reduce the salt content of food items. This is in line with the American Public Health Association resolution, which postulates that food manufacturers and restaurants should reduce sodium in the food supply by 50% during the next decade [<xref ref-type="bibr" rid="CR49">49</xref>]. We realize that this is a hot political issue, which has provoked an intense political debate [<xref ref-type="bibr" rid="CR50">50</xref>].</p><p>It has been suggested that, apart from this political resistance against the reduction of salt intake, latent historical reminiscences may charge the issue emotionally [<xref ref-type="bibr" rid="CR51">51</xref>].</p></sec><sec id="Sec8"><title>Resistance to salt restriction&#x02014;historical reminiscences</title><p>As shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, salt intake in the era of hunters and gatherers was very low, presumably less than 1&#x000a0;g per day. It was only during the agricultural revolution and the associated population growth that higher salt intake became a necessity. The current high levels of salt intake, however, were reached only when salt became available as an article of commerce.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Increase of salt intake during evolution. Courtesy of Dr. P. Ferrari, Department of Nephrology, Fremantle Hospital, Perth, Western Australia, Australia</p></caption><graphic position="anchor" xlink:href="467_2008_856_Fig2_HTML" id="MO2"/></fig></p><p>As emphasized by several authors, the history of salt as a scarce product of vital importance for survival left presumably historical reminiscences which perpetuate the notion that salt is a valuable essential constituent of the diet [<xref ref-type="bibr" rid="CR52">52</xref>]. In many cultures around the world, salt, a white substance, is a symbol of the immaculate, the incorruptible, the imperishable, as reflected by the Arabian proverb &#x0201c;Salt is not worm eaten&#x0201d;. It has been an emblem of immortality and a symbol of immutable loyalty, as reflected by the sharing of bread and salt with a guest, a custom still alive in Slavic countries. In the past, ratifying contracts and sealing covenants included the use of salt, as reflected by the quotations in the Bible &#x0201c;It is a covenant of salt forever, before the Lord&#x0201d; (Numbers 18:&#x000a0;19) and &#x0201c;The Lord God of Israel gave the Kingdom over Israel to David forever, even to him and his sons by a covenant of salt&#x0201d; (2&#x000a0;Chronicles 13:&#x000a0;5). Paradoxically from today&#x02019;s perspective, in ancient Rome salt was even regarded as a symbol of health. This concept is still reflected by the words salus (health) and salubris (healthy) in Latin and the greeting &#x0201c;salut&#x0201d; in French. Officials and soldiers in ancient Rome did not receive money, but a fixed amount of salt (salarium) which is still reflected in the modern words salary (English), salaire (French), sold and soldier (English). Salt had enormous economic value, akin to gasoline today, and this explains why salt production was so important economically that the names of many cities still reflect past salt production: the syllable &#x0201c;wich&#x0201d;, pointing to an ancient saltern, is retained in names such as Sandwich, Ipswich; the Celtic word Hall for salt is still preserved in names such as Hall/Tirol, Halle/Saale; the Germanic words Salz and Salt are still preserved in names such as Salzburg, Langensalza and Saltcotes.</p><p>As a final remark, the salt tax was a major cause that sparked the French Revolution. Like the gasoline tax today, salt was an indispensable commodity and, for the authorities, an ideal object for taxation. This invited salt smuggling in pre-revolutionary France, which a special salt police (les gabelous) tried to suppress. They carried out military actions against salt smuggling, searched private property for hidden salt, and, notoriously, molested women (who were, however, frequently hiding smuggled salt in their underwear). The degree of oppression is reflected by the fact that, in the last year before the French Revolution, 3,500 citizens were sentenced to death or the galleys because of salt smuggling. This explains why, in the French Revolution, all salt tax officials were decapitated.</p></sec><sec id="Sec9"><title>The importance of salt balance on hemodialysis</title><p>When maintenance hemodialysis was introduced by Belding Scribner and colleagues in March 1960, they wrote 6&#x000a0;weeks later in their famous preliminary report [<xref ref-type="bibr" rid="CR53">53</xref>] &#x0201c;as in the case of nephrectomized dogs, hypertension appears to be influenced by the size of the extracellular space. The combination of dietary sodium restriction and ultrafiltration during dialysis permits the regulation of extracellular volume&#x0201d;. To his last days Scribner emphasized the method of drug-free salt restriction and ultrafiltration to control blood pressure [<xref ref-type="bibr" rid="CR54">54</xref>]. The high efficiency of a negative salt balance in controlling blood pressure of patients on dialysis was confirmed by numerous others. The original concept that the adverse effect of sodium was mediated exclusively via hypervolemia, as originally suggested by Guyton et al. [<xref ref-type="bibr" rid="CR55">55</xref>], must, to some extent, be modified, however, in the light of some recent observations by Titze and co-workers [<xref ref-type="bibr" rid="CR56">56</xref>], who showed that sodium can be stored in the skin and other organs in an osmotically inactive form. It is currently unknown whether this mechanism has repercussions on the blood pressure effect of a positive salt balance in humans. An attractive alternative hypothesis is that salt induced hypertension is the consequence of salt induced cardiotonic steroids (see below).</p><p>Obviously, hypervolemia per se does not necessarily raise blood pressure, as exemplified by the observation of low blood pressure in pregnancy, despite hypervolemia. Hypertension occurs only when the vascular resistance is inappropriately elevated (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Causes of inappropriately high vascular resistance in uremia</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cause</th></tr></thead><tbody><tr><td>Activated renin&#x02013;angiotensin system</td></tr><tr><td>Stimulated sympathetic nerve activity</td></tr><tr><td>Reduced breakdown of catecholamines (renalase)</td></tr><tr><td>Oxidative stress</td></tr><tr><td>Reduced endothelial cell-dependent dilatation (ROS)</td></tr><tr><td>Vascular remodeling with structurally fixed elevation of vascular resistance</td></tr></tbody></table></table-wrap></p><p>Only a few centers, e.g. Tassin, in France [<xref ref-type="bibr" rid="CR57">57</xref>], stuck to a rigorous low-salt diet and use of lower concentrations of sodium in the dialysate as proposed by Scribner. This strategy reduces extracellular volume and total peripheral resistance, yet, it is at the expense of increased norepinephrine and angiotensin II concentrations. Nevertheless, normal blood pressure values are achieved in the vast majority of patients. This is not explained by the prolonged dialysis times at the Tassin center, since similar blood pressure lowering by dietary salt restriction, ultrafiltration and reduction of dialysate sodium was also achieved in patients with dialyses of 5&#x000a0;h duration [<xref ref-type="bibr" rid="CR58">58</xref>]. By reducing salt intake and by aggressive ultrafiltration, Ozkahya [<xref ref-type="bibr" rid="CR59">59</xref>] even achieved regression of left ventricular hypertrophy without the use of anti-hypertensive drugs. That such a regime might require blockade of the counter-regulatory increase of the renin&#x02013;angiotensin system (RAS) (and possibly also of the sympathetic nerve system) was shown by Tycho Vuurmans and colleagues [<xref ref-type="bibr" rid="CR60">60</xref>]. They studied pulse wave velocity as an index of vascular stiffness: this parameter was not changed by administration of angiotensin-converting enzyme (ACE) inhibitors or by volume removal, yet it was normalized by the combination of the two maneuvers.</p><p>One further mechanism for how positive salt balance and hypervolemia may have adverse effects is the &#x02018;intestinal leak&#x02019; of endotoxin resulting from edema of the intestinal mucosa. In edematous patients with heart failure Niebauer et al. [<xref ref-type="bibr" rid="CR61">61</xref>] showed that transit of bacterial lipopolysaccharide across the intestinal mucosa and signs of micro-inflammation were reduced when the edema of the intestinal mucosa was reduced by diuretic treatment.</p></sec><sec id="Sec10"><title>Pathomechanisms underlying salt-induced target organ damage: cardiotonic steroids</title><p>Ever since Sir William Withering noted the therapeutic efficacy of foxglove in edematous patients with heart disease (&#x0201c;An Account of the Foxglove and some of its Medical Uses&#x0201d;, 1789) it had been suspected that digitalis acted as a substitute for an endogenous mammalian digitalis compound. The search for such a compound, however, was futile for a long time because of methodological limitations. Mammalian endogenous inhibitors of Na<sup>+</sup>, K<sup>+</sup> adenosine triphosphatase (ATPase) were found decades ago, but only recent methodological breakthroughs have permitted us to identify cardenoloids (ouabain, digoxin) and bufadienolides (marinobufagenin), i.e. substances which have marked effects on blood pressure, natriuresis and other functions [<xref ref-type="bibr" rid="CR38">38</xref>]. Marinobufagenin, which was originally found in the skin of toads, is natriuretic [<xref ref-type="bibr" rid="CR62">62</xref>]. Its blood concentration varies with changes in environmental salinity [<xref ref-type="bibr" rid="CR63">63</xref>]; it causes vasoconstriction in the mammalian organism [<xref ref-type="bibr" rid="CR64">64</xref>], and its concentration increases after volume expansion [<xref ref-type="bibr" rid="CR65">65</xref>] as well as in pathological states of volume expansion, e.g. uremia and pre-eclampsia [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR66">66</xref>].</p><p>The ideas concerning the mode of action of these compounds have recently undergone a transformation. In the past it had been assumed that these inhibitors of sodium potassium ATPase are inotropic in the heart because of an increase in intracellular calcium (Ca<sup>++</sup>) resulting from accumulation of intracellular sodium and backward running of the Na<sup>+</sup>Ca<sup>++</sup> exchanger. More recently, however, it has been found that they act as signal transducers at nanomolar or sub-nanomolar concentrations which do not inhibit the Na<sup>+</sup>,K<sup>+</sup>-ATPase: they bind to the extracellular domain of the &#x003b1;-1 chain of Na<sup>+</sup>, K<sup>+</sup>-ATPase, cause slow Ca<sup>++</sup> oscillations by interaction with the endoplasmic reticulum (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a), generate reactive oxygen species by acting on the mitochondria (via src, epidermal growth factor receptor (EGF-R), ras, raf, MEK) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b) and activate nuclear gene programs [<xref ref-type="bibr" rid="CR67">67</xref>], mainly as the result of the activation of nuclear factor-kappa B (NF&#x003ba;B) by the slow calcium oscillations (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c).<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Signaling pathways of cardiotonic steroids <bold>a</bold> Activation of NF&#x003ba;B via slow Ca<sup>++</sup> oscillations following modification of Ca<sup>++</sup> release from endoplasmic reticulum. <bold>b</bold> Activation of mitochondrial ROS via <italic>src</italic> and EGF-R. <bold>c</bold> Activation of nuclear gene programs via <italic>scr</italic> and EGF-R. <italic>PKC</italic> protein kinase C</p></caption><graphic position="anchor" xlink:href="467_2008_856_Fig3_HTML" id="MO3"/></fig></p><p>The signaling is mediated by interaction of the N-terminus of Na<sup>+</sup>,K<sup>+</sup>-ATPase with cardiotonic steroids, creating a so-called signalosome. Such signaling influences cell proliferation (apoptosis) and cell&#x02013;cell contact (cell migration)&#x02014;this has led to the development of anti-cancer agents. In the kidney, the effect of inhibiting apoptosis and stimulating cell proliferation via activating NF&#x003ba;B has been well documented [<xref ref-type="bibr" rid="CR68">68</xref>]. Such signaling also modulates natriuresis and blood pressure&#x02014;this even led to the development of novel anti-hypertensive substances [<xref ref-type="bibr" rid="CR69">69</xref>].</p><p>With respect to uremia, it is of considerable interest that, in subtotally nephrectomized rats, endogenous marinobufagenin concentrations are increased [<xref ref-type="bibr" rid="CR70">70</xref>]. If similar concentrations were achieved by infusing marinobufagenin in rats subjected to sham operation, cardiac hypertrophy with thickening of the left ventricular wall, cardiac fibrosis, diastolic malfunction and signaling via Src/ERK were observed. All these adverse effects could be prevented by pre-immunization, yielding neutralizing antibodies against marinobufagenin. In dialysis patients a correlation was found between endogenous ouabain by radio-immunosorbent assay (RIA) and mass spectrometry and left ventricular (LV) mass, LV volume and eccentric LV hypertrophy [<xref ref-type="bibr" rid="CR71">71</xref>].</p><p>It is likely that, apart from in the heart, cardiotonic steroids play a role in the genesis of other types of uremia-induced target organ damage as well.</p></sec><sec id="Sec11" sec-type="conclusion"><title>Conclusion</title><p>There is strong evidence that salt intake plays an important role in the genesis of hypertension and target organ damage. Both high and low sodium intake cause adverse effects. The average salt intake of healthy children and adults exceeds, by far, the recommendations of current guidelines. The sodium content of most commercially available food items is too high, and this accounts for nearly three-quarters of salt intake. The most important aspect of strategies to reduce salt intake is an effort to make the food industry reduce nutrient salt content. Especially in renal patients, diuretics are usually needed in addition to reduction of dietary salt intake. The fascinating insights into novel pathomechanisms underlying salt-induced target organ damage, e.g. cardiotonic steroids, may ultimately yield new therapeutic interventions.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denton</surname><given-names>D</given-names></name><name><surname>Weisinger</surname><given-names>R</given-names></name><name><surname>Mundy</surname><given-names>NI</given-names></name><name><surname>Wickings</surname><given-names>EJ</given-names></name><name><surname>Dixson</surname><given-names>A</given-names></name><name><surname>Moisson</surname><given-names>P</given-names></name><name><surname>Pingard</surname><given-names>AM</given-names></name><name><surname>Shade</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>D</given-names></name><name><surname>Ardaillou</surname><given-names>R</given-names></name><name><surname>Paillard</surname><given-names>F</given-names></name><name><surname>Chapman</surname><given-names>J</given-names></name><name><surname>Thillet</surname><given-names>J</given-names></name><name><surname>Michel</surname><given-names>JB</given-names></name></person-group><article-title>The effect of increased salt intake on blood pressure of chimpanzees</article-title><source>Nat Med</source><year>1995</year><volume>1</volume><fpage>1009</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1038/nm1095-1009</pub-id></citation><citation citation-type="display-unstructured">Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB (1995) The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1:1009&#x02013;1016 <pub-id pub-id-type="pmid">7489355</pub-id></citation></ref><ref id="CR2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Svetkey</surname><given-names>LP</given-names></name><name><surname>Vollmer</surname><given-names>WM</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Harsha</surname><given-names>D</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Conlin</surname><given-names>PR</given-names></name><name><surname>Miller</surname><given-names>ER</given-names></name><name><surname>Simons-Morton</surname><given-names>DG</given-names></name><name><surname>Karanja</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>PH</given-names></name><collab>DASH-Sodium Collaborative Research Group</collab></person-group><article-title>Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1056/NEJM200101043440101</pub-id></citation><citation citation-type="display-unstructured">Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3&#x02013;10 <pub-id pub-id-type="pmid">11136953</pub-id></citation></ref><ref id="CR3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Wowern</surname><given-names>F</given-names></name><name><surname>Frandsen</surname><given-names>E</given-names></name><name><surname>Burri</surname><given-names>P</given-names></name><name><surname>Willsteen</surname><given-names>G</given-names></name><name><surname>Aurell</surname><given-names>M</given-names></name><name><surname>Hulth&#x000e9;n</surname><given-names>UL</given-names></name></person-group><article-title>Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma</article-title><source>J Hypertens</source><year>2007</year><volume>25</volume><fpage>619</fpage><lpage>627</lpage></citation><citation citation-type="display-unstructured">Melander O, von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, Hulth&#x000e9;n UL (2007) Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens 25:619&#x02013;627 <pub-id pub-id-type="pmid">17278979</pub-id></citation></ref><ref id="CR4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cianciaruso</surname><given-names>B</given-names></name><name><surname>Bellizzi</surname><given-names>V</given-names></name><name><surname>Minutolo</surname><given-names>R</given-names></name><name><surname>Tavera</surname><given-names>A</given-names></name><name><surname>Capuano</surname><given-names>A</given-names></name><name><surname>Conte</surname><given-names>G</given-names></name><name><surname>Nicola</surname><given-names>L</given-names></name></person-group><article-title>Salt intake and renal outcome in patients with progressive renal disease</article-title><source>Miner Electrolyte Metab</source><year>1998</year><volume>24</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1159/000057385</pub-id></citation><citation citation-type="display-unstructured">Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L (1998) Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 24:296&#x02013;301 <pub-id pub-id-type="pmid">9554571</pub-id></citation></ref><ref id="CR5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreutz</surname><given-names>R</given-names></name><name><surname>Kovacevic</surname><given-names>L</given-names></name><name><surname>Schulz</surname><given-names>A</given-names></name><name><surname>Rothermund</surname><given-names>L</given-names></name><name><surname>Ketteler</surname><given-names>M</given-names></name><name><surname>Paul</surname><given-names>M</given-names></name></person-group><article-title>Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number</article-title><source>J Hypertens</source><year>2000</year><volume>18</volume><fpage>777</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1097/00004872-200018060-00017</pub-id></citation><citation citation-type="display-unstructured">Kreutz R, Kovacevic L, Schulz A, Rothermund L, Ketteler M, Paul M (2000) Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number. J Hypertens 18:777&#x02013;782 <pub-id pub-id-type="pmid">10872564</pub-id></citation></ref><ref id="CR6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simons-Morton</surname><given-names>DG</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name></person-group><article-title>Diet and blood pressure in children and adolescents</article-title><source>Pediatr Nephrol</source><year>1997</year><volume>11</volume><fpage>244</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1007/s004670050271</pub-id></citation><citation citation-type="display-unstructured">Simons-Morton DG, Obarzanek E (1997) Diet and blood pressure in children and adolescents. Pediatr Nephrol 11:244&#x02013;249 <pub-id pub-id-type="pmid">9090675</pub-id></citation></ref><ref id="CR7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name></person-group><article-title>Correlations between salt intake, blood pressure, and family history of hypertension</article-title><source>Am J Clin Nutr</source><year>1980</year><volume>33</volume><fpage>2218</fpage><lpage>2220</lpage></citation><citation citation-type="display-unstructured">Cooper R, Liu K (1980) Correlations between salt intake, blood pressure, and family history of hypertension. Am J Clin Nutr 33:2218&#x02013;2220 <pub-id pub-id-type="pmid">7424816</pub-id></citation></ref><ref id="CR8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geleijnse</surname><given-names>JM</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Hazebroek</surname><given-names>AA</given-names></name><name><surname>Valkenburg</surname><given-names>HA</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name></person-group><article-title>Long-term effects of neonatal sodium restriction on blood pressure</article-title><source>Hypertension</source><year>1997</year><volume>29</volume><fpage>913</fpage><lpage>917</lpage></citation><citation citation-type="display-unstructured">Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE (1997) Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 29:913&#x02013;917 <pub-id pub-id-type="pmid">9095076</pub-id></citation></ref><ref id="CR9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>MacGregor</surname><given-names>GA</given-names></name></person-group><article-title>Importance of salt in determining blood pressure in children: meta-analysis of controlled trials</article-title><source>Hypertension</source><year>2006</year><volume>48</volume><fpage>861</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000245672.27270.4a</pub-id></citation><citation citation-type="display-unstructured">He FJ, MacGregor GA (2006) Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 48:861&#x02013;869 <pub-id pub-id-type="pmid">17000923</pub-id></citation></ref><ref id="CR10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>DL</given-names></name><name><surname>Mistretta</surname><given-names>CM</given-names></name><name><surname>Bradley</surname><given-names>RM</given-names></name></person-group><article-title>Effects of dietary NaCl deprivation during early development on behavioral and neurophysiological taste responses</article-title><source>Behav Neurosci</source><year>1986</year><volume>100</volume><fpage>390</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1037/0735-7044.100.3.390</pub-id></citation><citation citation-type="display-unstructured">Hill DL, Mistretta CM, Bradley RM (1986) Effects of dietary NaCl deprivation during early development on behavioral and neurophysiological taste responses. Behav Neurosci 100:390&#x02013;398 <pub-id pub-id-type="pmid">3730147</pub-id></citation></ref><ref id="CR11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>KS</given-names></name><name><surname>Krause</surname><given-names>EG</given-names></name><name><surname>Wong</surname><given-names>DL</given-names></name><name><surname>Contreras</surname><given-names>RJ</given-names></name></person-group><article-title>Gestational and early postnatal dietary NaCl levels affect NaCl intake, but not stimulated water intake, by adult rats</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2004</year><volume>286</volume><fpage>R1043</fpage><lpage>1050</lpage></citation><citation citation-type="display-unstructured">Curtis KS, Krause EG, Wong DL, Contreras RJ (2004) Gestational and early postnatal dietary NaCl levels affect NaCl intake, but not stimulated water intake, by adult rats. Am J Physiol Regul Integr Comp Physiol 286:R1043&#x02013;1050 <pub-id pub-id-type="pmid">14764435</pub-id></citation></ref><ref id="CR12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>MG</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name><name><surname>Guerra</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Prenatal programming of hypernatremia and hypertension in neonatal lambs</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2005</year><volume>288</volume><fpage>R97</fpage><lpage>103</lpage></citation><citation citation-type="display-unstructured">Ross MG, Desai M, Guerra C, Wang S (2005) Prenatal programming of hypernatremia and hypertension in neonatal lambs. Am J Physiol Regul Integr Comp Physiol 288:R97&#x02013;103 <pub-id pub-id-type="pmid">15374819</pub-id></citation></ref><ref id="CR13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crystal</surname><given-names>SR</given-names></name><name><surname>Bernstein</surname><given-names>IL</given-names></name></person-group><article-title>Morning sickness: impact on offspring salt preference</article-title><source>Appetite</source><year>1995</year><volume>25</volume><fpage>231</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1006/appe.1995.0058</pub-id></citation><citation citation-type="display-unstructured">Crystal SR, Bernstein IL (1995) Morning sickness: impact on offspring salt preference. Appetite 25:231&#x02013;240 <pub-id pub-id-type="pmid">8746963</pub-id></citation></ref><ref id="CR14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e1;laga</surname><given-names>I</given-names></name><name><surname>Arguelles</surname><given-names>J</given-names></name><name><surname>Diaz</surname><given-names>JJ</given-names></name><name><surname>Perillan</surname><given-names>C</given-names></name><name><surname>Vijande</surname><given-names>M</given-names></name><name><surname>M&#x000e1;laga</surname><given-names>S</given-names></name></person-group><article-title>Maternal pregnancy vomiting and offspring salt taste sensitivity and blood pressure</article-title><source>Pediatr Nephrol</source><year>2005</year><volume>20</volume><fpage>956</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1007/s00467-005-1852-6</pub-id></citation><citation citation-type="display-unstructured">M&#x000e1;laga I, Arguelles J, Diaz JJ, Perillan C, Vijande M, M&#x000e1;laga S (2005) Maternal pregnancy vomiting and offspring salt taste sensitivity and blood pressure. Pediatr Nephrol 20:956&#x02013;960 <pub-id pub-id-type="pmid">15864654</pub-id></citation></ref><ref id="CR15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>LJ</given-names></name><name><surname>Cowart</surname><given-names>BJ</given-names></name><name><surname>Epstein</surname><given-names>AN</given-names></name><name><surname>Pilot</surname><given-names>LJ</given-names></name><name><surname>Laskin</surname><given-names>CR</given-names></name><name><surname>Beauchamp</surname><given-names>GK</given-names></name></person-group><article-title>Increased liking for salty foods in adolescents exposed during infancy to a chloride-deficient feeding formula</article-title><source>Appetite</source><year>1996</year><volume>27</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1006/appe.1996.0034</pub-id></citation><citation citation-type="display-unstructured">Stein LJ, Cowart BJ, Epstein AN, Pilot LJ, Laskin CR, Beauchamp GK (1996) Increased liking for salty foods in adolescents exposed during infancy to a chloride-deficient feeding formula. Appetite 27:65&#x02013;77 <pub-id pub-id-type="pmid">8879420</pub-id></citation></ref><ref id="CR16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>JP</given-names></name><name><surname>King</surname><given-names>SH</given-names></name><name><surname>Honeycutt</surname><given-names>AD</given-names></name></person-group><article-title>Prenatal high-salt diet in the Sprague-Dawley rat programs blood pressure and heart rate hyperresponsiveness to stress in adult female offspring</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>293</volume><fpage>R334</fpage><lpage>342</lpage></citation><citation citation-type="display-unstructured">Porter JP, King SH, Honeycutt AD (2007) Prenatal high-salt diet in the Sprague-Dawley rat programs blood pressure and heart rate hyperresponsiveness to stress in adult female offspring. Am J Physiol Regul Integr Comp Physiol 293:R334&#x02013;342 <pub-id pub-id-type="pmid">17491116</pub-id></citation></ref><ref id="CR17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boer</surname><given-names>MP</given-names></name><name><surname>IJzerman</surname><given-names>RG</given-names></name><name><surname>Jongh</surname><given-names>RT</given-names></name><name><surname>Eringa</surname><given-names>EC</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name><name><surname>Smulders</surname><given-names>YM</given-names></name><name><surname>Sern&#x000e9;</surname><given-names>EH</given-names></name></person-group><article-title>Birth weight relates to salt sensitivity of blood pressure in healthy adults</article-title><source>Hypertension</source><year>2008</year><volume>51</volume><fpage>928</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.101881</pub-id></citation><citation citation-type="display-unstructured">de Boer MP, IJzerman RG, de Jongh RT, Eringa EC, Stehouwer CD, Smulders YM, Sern&#x000e9; EH (2008) Birth weight relates to salt sensitivity of blood pressure in healthy adults. Hypertension 51:928&#x02013;932 <pub-id pub-id-type="pmid">18287343</pub-id></citation></ref><ref id="CR18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orlov</surname><given-names>SN</given-names></name><name><surname>Mongin</surname><given-names>AA</given-names></name></person-group><article-title>Salt-sensing mechanisms in blood pressure regulation and hypertension</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2007</year><volume>293</volume><fpage>H2039</fpage><lpage>2053</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00325.2007</pub-id></citation><citation citation-type="display-unstructured">Orlov SN, Mongin AA (2007) Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 293:H2039&#x02013;2053 <pub-id pub-id-type="pmid">17693546</pub-id></citation></ref><ref id="CR19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>M</given-names></name><name><surname>Sanchez-Lozada</surname><given-names>LG</given-names></name><name><surname>Bautista</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Rodriguez-Iturbe</surname><given-names>B</given-names></name></person-group><article-title>Pathophysiology of salt-sensitive hypertension: a new scope of an old problem</article-title><source>Blood Purif</source><year>2008</year><volume>26</volume><fpage>45</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1159/000110563</pub-id></citation><citation citation-type="display-unstructured">Franco M, Sanchez-Lozada LG, Bautista R, Johnson RJ, Rodriguez-Iturbe B (2008) Pathophysiology of salt-sensitive hypertension: a new scope of an old problem. Blood Purif 26:45&#x02013;8 <pub-id pub-id-type="pmid">18182795</pub-id></citation></ref><ref id="CR20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Rastenyte</surname><given-names>D</given-names></name><name><surname>Moltchanov</surname><given-names>V</given-names></name><name><surname>Tanskanen</surname><given-names>A</given-names></name><name><surname>Pietinen</surname><given-names>P</given-names></name><name><surname>Nissinen</surname><given-names>A</given-names></name></person-group><article-title>Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)04199-4</pub-id></citation><citation citation-type="display-unstructured">Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A (2001) Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 357:848&#x02013;851 <pub-id pub-id-type="pmid">11265954</pub-id></citation></ref><ref id="CR21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Rexrode</surname><given-names>KM</given-names></name><name><surname>Kumanyika</surname><given-names>SK</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name></person-group><article-title>Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)</article-title><source>BMJ</source><year>2007</year><volume>334</volume><fpage>885</fpage><pub-id pub-id-type="doi">10.1136/bmj.39147.604896.55</pub-id></citation><citation citation-type="display-unstructured">Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334:885 <pub-id pub-id-type="pmid">17449506</pub-id></citation></ref><ref id="CR22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verhave</surname><given-names>JC</given-names></name><name><surname>Hillege</surname><given-names>HL</given-names></name><name><surname>Burgerhof</surname><given-names>JG</given-names></name><name><surname>Janssen</surname><given-names>WM</given-names></name><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Navis</surname><given-names>GJ</given-names></name><name><surname>Zeeuw</surname><given-names>D</given-names></name><name><surname>Jong</surname><given-names>PE</given-names></name><collab>PREVEND Study Group</collab></person-group><article-title>Sodium intake affects urinary albumin excretion especially in overweight subjects</article-title><source>J Intern Med</source><year>2004</year><volume>256</volume><fpage>324</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01390.x</pub-id></citation><citation citation-type="display-unstructured">Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE, PREVEND Study Group (2004) Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256:324&#x02013;330 <pub-id pub-id-type="pmid">15367175</pub-id></citation></ref><ref id="CR23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>PW</given-names></name></person-group><article-title>Effect of salt intake on progression of chronic kidney disease</article-title><source>Curr Opin Nephrol Hypertens</source><year>2006</year><volume>15</volume><fpage>54</fpage><lpage>60</lpage></citation><citation citation-type="display-unstructured">Sanders PW (2006) Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 15:54&#x02013;60 <pub-id pub-id-type="pmid">16340667</pub-id></citation></ref><ref id="CR24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>MW</given-names></name><name><surname>Fazzi</surname><given-names>GE</given-names></name><name><surname>Janssen</surname><given-names>GM</given-names></name><name><surname>Blanco</surname><given-names>CE</given-names></name><name><surname>Mey</surname><given-names>JG</given-names></name></person-group><article-title>High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats</article-title><source>Hypertension</source><year>2005</year><volume>46</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000171475.40259.d1</pub-id></citation><citation citation-type="display-unstructured">Sanders MW, Fazzi GE, Janssen GM, Blanco CE, De Mey JG (2005) High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension 46:71&#x02013;75 <pub-id pub-id-type="pmid">15956110</pub-id></citation></ref><ref id="CR25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dworkin</surname><given-names>LD</given-names></name><name><surname>Benstein</surname><given-names>JA</given-names></name><name><surname>Tolbert</surname><given-names>E</given-names></name><name><surname>Feiner</surname><given-names>HD</given-names></name></person-group><article-title>Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease</article-title><source>J Am Soc Nephrol</source><year>1996</year><volume>7</volume><fpage>437</fpage><lpage>442</lpage></citation><citation citation-type="display-unstructured">Dworkin LD, Benstein JA, Tolbert E, Feiner HD (1996) Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 7:437&#x02013;442 <pub-id pub-id-type="pmid">8704110</pub-id></citation></ref><ref id="CR26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>HC</given-names></name><name><surname>Burrell</surname><given-names>LM</given-names></name><name><surname>Black</surname><given-names>MJ</given-names></name><name><surname>Wu</surname><given-names>LL</given-names></name><name><surname>Dilley</surname><given-names>RJ</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Johnston</surname><given-names>CI</given-names></name></person-group><article-title>Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>2621</fpage><lpage>2628</lpage></citation><citation citation-type="display-unstructured">Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI (1998) Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621&#x02013;2628 <pub-id pub-id-type="pmid">9843472</pub-id></citation></ref><ref id="CR27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>PW</given-names></name><name><surname>Gibbs</surname><given-names>CL</given-names></name><name><surname>Akhi</surname><given-names>KM</given-names></name><name><surname>MacMillan-Crow</surname><given-names>LA</given-names></name><name><surname>Zinn</surname><given-names>KR</given-names></name><name><surname>Chen</surname><given-names>YF</given-names></name><name><surname>Young</surname><given-names>CJ</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name></person-group><article-title>Increased dietary salt accelerates chronic allograft nephropathy in rats</article-title><source>Kidney Int</source><year>2001</year><volume>59</volume><fpage>1149</fpage><lpage>1157</lpage></citation><citation citation-type="display-unstructured">Sanders PW, Gibbs CL, Akhi KM, MacMillan-Crow LA, Zinn KR, Chen YF, Young CJ, Thompson JA (2001) Increased dietary salt accelerates chronic allograft nephropathy in rats. Kidney Int 59:1149&#x02013;1157 <pub-id pub-id-type="pmid">11231373</pub-id></citation></ref><ref id="CR28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>WZ</given-names></name><name><surname>Sanders</surname><given-names>PW</given-names></name></person-group><article-title>Dietary salt modulates renal production of transforming growth factor-beta in rats</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>F635</fpage><lpage>641</lpage></citation><citation citation-type="display-unstructured">Ying WZ, Sanders PW (1998) Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol 274:F635&#x02013;641 <pub-id pub-id-type="pmid">9575885</pub-id></citation></ref><ref id="CR29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buter</surname><given-names>H</given-names></name><name><surname>Hemmelder</surname><given-names>MH</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>Jong</surname><given-names>PE</given-names></name><name><surname>Zeeuw</surname><given-names>D</given-names></name></person-group><article-title>The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide</article-title><source>Nephrol Dial Transplant</source><year>1998</year><volume>13</volume><fpage>1682</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1093/ndt/13.7.1682</pub-id></citation><citation citation-type="display-unstructured">Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D (1998) The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 13:1682&#x02013;1685 <pub-id pub-id-type="pmid">9681711</pub-id></citation></ref><ref id="CR30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koomans</surname><given-names>HA</given-names></name><name><surname>Roos</surname><given-names>JC</given-names></name><name><surname>Dorhout Mees</surname><given-names>EJ</given-names></name><name><surname>Delawi</surname><given-names>IM</given-names></name></person-group><article-title>Sodium balance in renal failure</article-title><source>A comparison of patients with normal subjects under extremes of sodium intake. Hypertension</source><year>1985</year><volume>7</volume><fpage>714</fpage><lpage>721</lpage></citation><citation citation-type="display-unstructured">Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM (1985) Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension 7:714&#x02013;721 </citation></ref><ref id="CR31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaparzadeh</surname><given-names>N</given-names></name><name><surname>D</surname></name><name><surname>Amico</surname><given-names>ML</given-names></name><name><surname>Khavari-Nejad</surname><given-names>RA</given-names></name><name><surname>Izzo</surname><given-names>R</given-names></name><name><surname>Navari-Izzo</surname><given-names>F</given-names></name></person-group><article-title>Antioxidative responses of Calendula officinalis under salinity conditions</article-title><source>Plant Physiol Biochem</source><year>2004</year><volume>42</volume><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.plaphy.2004.07.001</pub-id></citation><citation citation-type="display-unstructured">Chaparzadeh N, D, Amico ML, Khavari-Nejad RA, Izzo R, Navari-Izzo F (2004) Antioxidative responses of Calendula officinalis under salinity conditions. Plant Physiol Biochem 42:695&#x02013;701 <pub-id pub-id-type="pmid">15474374</pub-id></citation></ref><ref id="CR32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitiyakara</surname><given-names>C</given-names></name><name><surname>Chabrashvili</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Blau</surname><given-names>J</given-names></name><name><surname>Karber</surname><given-names>A</given-names></name><name><surname>Aslam</surname><given-names>S</given-names></name><name><surname>Welch</surname><given-names>WJ</given-names></name><name><surname>Wilcox</surname><given-names>CS</given-names></name></person-group><article-title>Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase</article-title><source>J Am Soc Nephrol</source><year>2003</year><volume>14</volume><fpage>2775</fpage><lpage>2782</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000092145.90389.65</pub-id></citation><citation citation-type="display-unstructured">Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS (2003) Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14:2775&#x02013;2782 <pub-id pub-id-type="pmid">14569087</pub-id></citation></ref><ref id="CR33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>PW</given-names></name></person-group><article-title>Salt intake, endothelial cell signaling, and progression of kidney disease</article-title><source>Hypertension</source><year>2004</year><volume>43</volume><fpage>142</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000114022.20424.22</pub-id></citation><citation citation-type="display-unstructured">Sanders PW (2004) Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43:142&#x02013;146 <pub-id pub-id-type="pmid">14707151</pub-id></citation></ref><ref id="CR34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Kihara</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Koide</surname><given-names>Y</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Hirawa</surname><given-names>N</given-names></name><name><surname>Toya</surname><given-names>Y</given-names></name><name><surname>Fukamizu</surname><given-names>A</given-names></name><name><surname>Umemura</surname><given-names>S</given-names></name></person-group><article-title>Alterations in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>1756</fpage><lpage>1763</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000130922.75125.B8</pub-id></citation><citation citation-type="display-unstructured">Sato K, Kihara M, Hashimoto T, Matsushita K, Koide Y, Tamura K, Hirawa N, Toya Y, Fukamizu A, Umemura S (2004) Alterations in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice. J Am Soc Nephrol 15:1756&#x02013;1763 <pub-id pub-id-type="pmid">15213263</pub-id></citation></ref><ref id="CR35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Ikegaya</surname><given-names>N</given-names></name><name><surname>Hishida</surname><given-names>A</given-names></name></person-group><article-title>Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression</article-title><source>Am J Physiol Renal Physiol</source><year>2004</year><volume>286</volume><fpage>F267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00059.2003</pub-id></citation><citation citation-type="display-unstructured">Suzuki H, Yamamoto T, Ikegaya N, Hishida A (2004) Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. Am J Physiol Renal Physiol 286:F267&#x02013;277 <pub-id pub-id-type="pmid">14559715</pub-id></citation></ref><ref id="CR36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivanovski</surname><given-names>O</given-names></name><name><surname>Szumilak</surname><given-names>D</given-names></name><name><surname>Nguyen-Khoa</surname><given-names>T</given-names></name><name><surname>Dechaux</surname><given-names>M</given-names></name><name><surname>Massy</surname><given-names>ZA</given-names></name><name><surname>Phan</surname><given-names>O</given-names></name><name><surname>Mothu</surname><given-names>N</given-names></name><name><surname>Lacour</surname><given-names>B</given-names></name><name><surname>Drueke</surname><given-names>TB</given-names></name><name><surname>Muntzel</surname><given-names>M</given-names></name></person-group><article-title>Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice</article-title><source>Atherosclerosis</source><year>2005</year><volume>180</volume><fpage>271</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2004.12.020</pub-id></citation><citation citation-type="display-unstructured">Ivanovski O, Szumilak D, Nguyen-Khoa T, Dechaux M, Massy ZA, Phan O, Mothu N, Lacour B, Drueke TB, Muntzel M (2005) Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 180:271&#x02013;276 <pub-id pub-id-type="pmid">15910852</pub-id></citation></ref><ref id="CR37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Battista</surname><given-names>MC</given-names></name><name><surname>Oligny</surname><given-names>LL</given-names></name><name><surname>St-Louis</surname><given-names>J</given-names></name><name><surname>Brochu</surname><given-names>M</given-names></name></person-group><article-title>Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood</article-title><source>Am J Physiol Endocrinol Metab</source><year>2002</year><volume>283</volume><fpage>E124</fpage><lpage>131</lpage></citation><citation citation-type="display-unstructured">Battista MC, Oligny LL, St-Louis J, Brochu M (2002) Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood. Am J Physiol Endocrinol Metab 283:E124&#x02013;131 <pub-id pub-id-type="pmid">12067852</pub-id></citation></ref><ref id="CR38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schoner</surname><given-names>W</given-names></name><name><surname>Scheiner-Bobis</surname><given-names>G</given-names></name></person-group><article-title>Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth</article-title><source>Am J Physiol Cell Physiol</source><year>2007</year><volume>293</volume><fpage>C509</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00098.2007</pub-id></citation><citation citation-type="display-unstructured">Schoner W, Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293:C509&#x02013;536 <pub-id pub-id-type="pmid">17494630</pub-id></citation></ref><ref id="CR39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sowers</surname><given-names>JR</given-names></name></person-group><article-title>Hypertension, angiotensin II, and oxidative stress</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>1999</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1056/NEJMe020054</pub-id></citation><citation citation-type="display-unstructured">Sowers JR (2002) Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346:1999&#x02013;2001 <pub-id pub-id-type="pmid">12075063</pub-id></citation></ref><ref id="CR40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Backer</surname><given-names>G</given-names></name><name><surname>Dominiczak</surname><given-names>A</given-names></name><name><surname>Cifkova</surname><given-names>R</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Germano</surname><given-names>G</given-names></name><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Heagerty</surname><given-names>AM</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><name><surname>Narkiewicz</surname><given-names>K</given-names></name><name><surname>Ruilope</surname><given-names>L</given-names></name><name><surname>Rynkiewicz</surname><given-names>A</given-names></name><name><surname>Schmieder</surname><given-names>RE</given-names></name><name><surname>Boudier</surname><given-names>HA</given-names></name><name><surname>Zanchetti</surname><given-names>A</given-names></name><name><surname>Vahanian</surname><given-names>A</given-names></name><name><surname>Camm</surname><given-names>J</given-names></name><name><surname>Caterina</surname><given-names>R</given-names></name><name><surname>Dean</surname><given-names>V</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><name><surname>Filippatos</surname><given-names>G</given-names></name><name><surname>Funck-Brentano</surname><given-names>C</given-names></name><name><surname>Hellemans</surname><given-names>I</given-names></name><name><surname>Kristensen</surname><given-names>SD</given-names></name><name><surname>McGregor</surname><given-names>K</given-names></name><name><surname>Sechtem</surname><given-names>U</given-names></name><name><surname>Silber</surname><given-names>S</given-names></name><name><surname>Tendera</surname><given-names>M</given-names></name><name><surname>Widimsky</surname><given-names>P</given-names></name><name><surname>Zamorano</surname><given-names>JL</given-names></name><name><surname>Erdine</surname><given-names>S</given-names></name><name><surname>Kiowski</surname><given-names>W</given-names></name><name><surname>Agabiti-Rosei</surname><given-names>E</given-names></name><name><surname>Ambrosioni</surname><given-names>E</given-names></name><name><surname>Lindholm</surname><given-names>LH</given-names></name><name><surname>Viigimaa</surname><given-names>M</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Agabiti-Rosei</surname><given-names>E</given-names></name><name><surname>Ambrosioni</surname><given-names>E</given-names></name><name><surname>Bertomeu</surname><given-names>V</given-names></name><name><surname>Clement</surname><given-names>D</given-names></name><name><surname>Erdine</surname><given-names>S</given-names></name><name><surname>Farsang</surname><given-names>C</given-names></name><name><surname>Gaita</surname><given-names>D</given-names></name><name><surname>Lip</surname><given-names>G</given-names></name><name><surname>Mallion</surname><given-names>JM</given-names></name><name><surname>Manolis</surname><given-names>AJ</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>E</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Redon</surname><given-names>J</given-names></name><name><surname>Ruschitzka</surname><given-names>F</given-names></name><name><surname>Tamargo</surname><given-names>J</given-names></name><name><surname>Zwieten</surname><given-names>P</given-names></name><name><surname>Waeber</surname><given-names>B</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><collab>Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology</collab></person-group><article-title>2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)</article-title><source>J Hypertens</source><year>2007</year><volume>25</volume><fpage>1105</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e3281fc975a</pub-id></citation><citation citation-type="display-unstructured">Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O&#x02019;Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105&#x02013;1187 <pub-id pub-id-type="pmid">17563527</pub-id></citation></ref><ref id="CR41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JB</given-names></name></person-group><article-title>Reduced sodium chloride intake normalises blood pressure distribution</article-title><source>J Hum Hypertens</source><year>1989</year><volume>3</volume><fpage>97</fpage><lpage>104</lpage></citation><citation citation-type="display-unstructured">Myers JB (1989) Reduced sodium chloride intake normalises blood pressure distribution. J Hum Hypertens 3:97&#x02013;104 <pub-id pub-id-type="pmid">2760911</pub-id></citation></ref><ref id="CR42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinaiko</surname><given-names>AR</given-names></name><name><surname>Gomez-Marin</surname><given-names>O</given-names></name><name><surname>Prineas</surname><given-names>RJ</given-names></name></person-group><article-title>Effect of low sodium diet or potassium supplementation on adolescent blood pressure</article-title><source>Hypertension</source><year>1993</year><volume>21</volume><fpage>989</fpage><lpage>994</lpage></citation><citation citation-type="display-unstructured">Sinaiko AR, Gomez-Marin O, Prineas RJ (1993) Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension 21:989&#x02013;994 <pub-id pub-id-type="pmid">8505112</pub-id></citation></ref><ref id="CR43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Courcy</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>H</given-names></name><name><surname>Simmons</surname><given-names>D</given-names></name><name><surname>MacGregor</surname><given-names>GA</given-names></name></person-group><article-title>Urinary sodium excretion in 4&#x02013;6 year old children: a cause for concern?</article-title><source>BMJ</source><year>1986</year><volume>292</volume><fpage>1428</fpage><lpage>1429</lpage></citation><citation citation-type="display-unstructured">De Courcy S, Mitchell H, Simmons D, MacGregor GA (1986) Urinary sodium excretion in 4&#x02013;6 year old children: a cause for concern? BMJ 292:1428&#x02013;1429 <pub-id pub-id-type="pmid">3087457</pub-id></citation></ref><ref id="CR44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>Marrero</surname><given-names>NM</given-names></name><name><surname>Macgregor</surname><given-names>GA</given-names></name></person-group><article-title>Salt and blood pressure in children and adolescents</article-title><source>J Hum Hypertens</source><year>2008</year><volume>22</volume><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/sj.jhh.1002268</pub-id></citation><citation citation-type="display-unstructured">He FJ, Marrero NM, Macgregor GA (2008) Salt and blood pressure in children and adolescents. J Hum Hypertens 22:4&#x02013;11 <pub-id pub-id-type="pmid">17823599</pub-id></citation></ref><ref id="CR45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>St-Onge</surname><given-names>MP</given-names></name><name><surname>Keller</surname><given-names>KL</given-names></name><name><surname>Heymsfield</surname><given-names>SB</given-names></name></person-group><article-title>Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>78</volume><fpage>1068</fpage><lpage>1073</lpage></citation><citation citation-type="display-unstructured">St-Onge MP, Keller KL, Heymsfield SB (2003) Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr 78:1068&#x02013;1073 <pub-id pub-id-type="pmid">14668265</pub-id></citation></ref><ref id="CR46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heino</surname><given-names>T</given-names></name><name><surname>Kallio</surname><given-names>K</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Lagstrom</surname><given-names>H</given-names></name><name><surname>Sepp&#x000e4;nen</surname><given-names>R</given-names></name><name><surname>V&#x000e4;lim&#x000e4;ki</surname><given-names>I</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>R&#x000f6;nnemaa</surname><given-names>T</given-names></name><name><surname>Simell</surname><given-names>O</given-names></name></person-group><article-title>Sodium intake of 1 to 5-year-old children: the STRIP project. The special turku coronary risk factor intervention project</article-title><source>Acta Paediatr</source><year>2000</year><volume>89</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1080/080352500750028096</pub-id></citation><citation citation-type="display-unstructured">Heino T, Kallio K, Jokinen E, Lagstrom H, Sepp&#x000e4;nen R, V&#x000e4;lim&#x000e4;ki I, Viikari J, R&#x000f6;nnemaa T, Simell O (2000) Sodium intake of 1 to 5-year-old children: the STRIP project. The special turku coronary risk factor intervention project. Acta Paediatr 89:406&#x02013;410 <pub-id pub-id-type="pmid">10830450</pub-id></citation></ref><ref id="CR47"><label>47.</label><citation citation-type="other">Scientific Advisory Committee on Nutrition (2003) Salt and health&#x02014;draft report of SACN for consultation. Accessed at <ext-link ext-link-type="uri" xlink:href="http://www.sacn.gov.uk/pdfs/smcn_03_03.pdf">www.sacn.gov.uk/pdfs/smcn_03_03.pdf</ext-link></citation></ref><ref id="CR48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Castillo</surname><given-names>CP</given-names></name><name><surname>Warrender</surname><given-names>S</given-names></name><name><surname>Whitehead</surname><given-names>TP</given-names></name><name><surname>James</surname><given-names>WP</given-names></name></person-group><article-title>An assessment of the sources of dietary salt in a British population</article-title><source>Clin Sci (Lond)</source><year>1987</year><volume>72</volume><fpage>95</fpage><lpage>102</lpage></citation><citation citation-type="display-unstructured">Sanchez-Castillo CP, Warrender S, Whitehead TP, James WP (1987) An assessment of the sources of dietary salt in a British population. Clin Sci (Lond) 72:95&#x02013;102 <pub-id pub-id-type="pmid">3802726</pub-id></citation></ref><ref id="CR49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chobanian</surname><given-names>AV</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Green</surname><given-names>LA</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Materson</surname><given-names>BJ</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>JT</given-names></name><name><surname>Roccella</surname><given-names>EJ</given-names></name><collab>National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee</collab></person-group><article-title>The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>2560</fpage><lpage>2572</lpage><pub-id pub-id-type="doi">10.1001/jama.289.19.2560</pub-id></citation><citation citation-type="display-unstructured">Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560&#x02013;2572 <pub-id pub-id-type="pmid">12748199</pub-id></citation></ref><ref id="CR50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Awqati</surname><given-names>Q</given-names></name></person-group><article-title>Evidence-based politics of salt and blood pressure</article-title><source>Kidney Int</source><year>2006</year><volume>69</volume><fpage>1707</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5001520</pub-id></citation><citation citation-type="display-unstructured">Al-Awqati Q (2006) Evidence-based politics of salt and blood pressure. Kidney Int 69:1707&#x02013;1708 <pub-id pub-id-type="pmid">16688186</pub-id></citation></ref><ref id="CR51"><label>51.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Bergier</surname><given-names>JF</given-names></name></person-group><source>Une histoire du sel</source><year>1982</year><publisher-loc>Fribourg</publisher-loc><publisher-name>Office du Livre</publisher-name></citation><citation citation-type="display-unstructured">Bergier JF (1982) Une histoire du sel. Office du Livre, Fribourg </citation></ref><ref id="CR52"><label>52.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kurlansky</surname><given-names>M</given-names></name></person-group><source>Salt: a world history</source><year>2002</year><publisher-loc>London</publisher-loc><publisher-name>Vintage</publisher-name></citation><citation citation-type="display-unstructured">Kurlansky M (2002) Salt: a world history. Vintage, London </citation></ref><ref id="CR53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scribner</surname><given-names>BH</given-names></name><name><surname>Buri</surname><given-names>R</given-names></name><name><surname>Caner</surname><given-names>JE</given-names></name><name><surname>Hegstrom</surname><given-names>R</given-names></name><name><surname>Burnell</surname><given-names>JM</given-names></name></person-group><article-title>The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report</article-title><source>1960. J Am Soc Nephrol</source><year>1998</year><volume>9</volume><fpage>719</fpage><lpage>726</lpage></citation><citation citation-type="display-unstructured">Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM (1998) The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. 1960. J Am Soc Nephrol 9:719&#x02013;726 <pub-id pub-id-type="pmid">9555675</pub-id></citation></ref><ref id="CR54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charra</surname><given-names>B</given-names></name><name><surname>Bergstrom</surname><given-names>J</given-names></name><name><surname>Scribner</surname><given-names>BH</given-names></name></person-group><article-title>Blood pressure control in dialysis patients: importance of the lag phenomenon</article-title><source>Am J Kidney Dis</source><year>1998</year><volume>32</volume><fpage>720</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/S0272-6386(98)70147-7</pub-id></citation><citation citation-type="display-unstructured">Charra B, Bergstrom J, Scribner BH (1998) Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 32:720&#x02013;724 <pub-id pub-id-type="pmid">9820439</pub-id></citation></ref><ref id="CR55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guyton</surname><given-names>AC</given-names></name><name><surname>Cowley</surname><given-names>AW</given-names></name><name><surname>Young</surname><given-names>DB</given-names></name><name><surname>Coleman</surname><given-names>TG</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>DeClue</surname><given-names>JW</given-names></name></person-group><article-title>Integration and control of circulatory function</article-title><source>Int Rev Physiol</source><year>1976</year><volume>9</volume><fpage>341</fpage><lpage>385</lpage></citation><citation citation-type="display-unstructured">Guyton AC, Cowley AW Jr, Young DB, Coleman TG, Hall JE, DeClue JW (1976) Integration and control of circulatory function. Int Rev Physiol 9:341&#x02013;385 <pub-id pub-id-type="pmid">135739</pub-id></citation></ref><ref id="CR56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Titze</surname><given-names>J</given-names></name><name><surname>Shakibaei</surname><given-names>M</given-names></name><name><surname>Schafflhuber</surname><given-names>M</given-names></name><name><surname>Schulze-Tanzil</surname><given-names>G</given-names></name><name><surname>Porst</surname><given-names>M</given-names></name><name><surname>Schwind</surname><given-names>KH</given-names></name><name><surname>Dietsch</surname><given-names>P</given-names></name><name><surname>Hilgers</surname><given-names>KF</given-names></name></person-group><article-title>Glycosaminoglycan polymerization may enable osmotically inactive Na<sup>+</sup>&#x000a0;storage in the skin</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2004</year><volume>287</volume><fpage>H203</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01237.2003</pub-id></citation><citation citation-type="display-unstructured">Titze J, Shakibaei M, Schafflhuber M, Schulze-Tanzil G, Porst M, Schwind KH, Dietsch P, Hilgers KF (2004) Glycosaminoglycan polymerization may enable osmotically inactive Na+&#x000a0;storage in the skin. Am J Physiol Heart Circ Physiol 287:H203&#x02013;208 <pub-id pub-id-type="pmid">14975935</pub-id></citation></ref><ref id="CR57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charra</surname><given-names>B</given-names></name><name><surname>Calemard</surname><given-names>E</given-names></name><name><surname>Ruffet</surname><given-names>M</given-names></name><name><surname>Chazot</surname><given-names>C</given-names></name><name><surname>Terrat</surname><given-names>JC</given-names></name><name><surname>Vanel</surname><given-names>T</given-names></name><name><surname>Laurent</surname><given-names>G</given-names></name></person-group><article-title>Survival as an index of adequacy of dialysis</article-title><source>Kidney Int</source><year>1992</year><volume>41</volume><fpage>1286</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1038/ki.1992.191</pub-id></citation><citation citation-type="display-unstructured">Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G (1992) Survival as an index of adequacy of dialysis. Kidney Int 41:1286&#x02013;1291 <pub-id pub-id-type="pmid">1614043</pub-id></citation></ref><ref id="CR58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krautzig</surname><given-names>S</given-names></name><name><surname>Janssen</surname><given-names>U</given-names></name><name><surname>Koch</surname><given-names>KM</given-names></name><name><surname>Granolleras</surname><given-names>C</given-names></name><name><surname>Shaldon</surname><given-names>S</given-names></name></person-group><article-title>Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients</article-title><source>Nephrol Dial Transplant</source><year>1998</year><volume>13</volume><fpage>552</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1093/ndt/13.3.552</pub-id></citation><citation citation-type="display-unstructured">Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S (1998) Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 13:552&#x02013;553 <pub-id pub-id-type="pmid">9550625</pub-id></citation></ref><ref id="CR59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozkahya</surname><given-names>M</given-names></name><name><surname>Ok</surname><given-names>E</given-names></name><name><surname>Cirit</surname><given-names>M</given-names></name><name><surname>Aydin</surname><given-names>S</given-names></name><name><surname>Ak&#x000e7;i&#x000e7;ek</surname><given-names>F</given-names></name><name><surname>Ba&#x0015f;&#x000e7;i</surname><given-names>A</given-names></name><name><surname>Dorhout Mees</surname><given-names>EJ</given-names></name></person-group><article-title>Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs</article-title><source>Nephrol Dial Transplant</source><year>1998</year><volume>13</volume><fpage>1489</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1093/ndt/13.6.1489</pub-id></citation><citation citation-type="display-unstructured">Ozkahya M, Ok E, Cirit M, Aydin S, Ak&#x000e7;i&#x000e7;ek F, Ba&#x0015f;&#x000e7;i A, Dorhout Mees EJ (1998) Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 13:1489&#x02013;1493 <pub-id pub-id-type="pmid">9641180</pub-id></citation></ref><ref id="CR60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tycho Vuurmans</surname><given-names>JL</given-names></name><name><surname>Boer</surname><given-names>WH</given-names></name><name><surname>Bos</surname><given-names>WJ</given-names></name><name><surname>Blankestijn</surname><given-names>PJ</given-names></name><name><surname>Koomans</surname><given-names>HA</given-names></name></person-group><article-title>Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>177</fpage><lpage>183</lpage></citation><citation citation-type="display-unstructured">Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA (2002) Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13:177&#x02013;183 <pub-id pub-id-type="pmid">11752035</pub-id></citation></ref><ref id="CR61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niebauer</surname><given-names>J</given-names></name><name><surname>Volk</surname><given-names>HD</given-names></name><name><surname>Kemp</surname><given-names>M</given-names></name><name><surname>Dominguez</surname><given-names>M</given-names></name><name><surname>Schumann</surname><given-names>RR</given-names></name><name><surname>Rauchhaus</surname><given-names>M</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name></person-group><article-title>Endotoxin and immune activation in chronic heart failure: a prospective cohort study</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>1838</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(98)09286-1</pub-id></citation><citation citation-type="display-unstructured">Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838&#x02013;1842 <pub-id pub-id-type="pmid">10359409</pub-id></citation></ref><ref id="CR62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flier</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>MW</given-names></name><name><surname>Daly</surname><given-names>JW</given-names></name><name><surname>Myers</surname><given-names>CW</given-names></name></person-group><article-title>Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na&#x000a0;+&#x000a0;, K&#x000a0;+&#x000a0;-ATPase</article-title><source>Science</source><year>1980</year><volume>208</volume><fpage>503</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1126/science.6245447</pub-id></citation><citation citation-type="display-unstructured">Flier J, Edwards MW, Daly JW, Myers CW (1980) Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na&#x000a0;+&#x000a0;, K&#x000a0;+-ATPase. Science 208:503&#x02013;505 <pub-id pub-id-type="pmid">6245447</pub-id></citation></ref><ref id="CR63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lichtstein</surname><given-names>D</given-names></name><name><surname>Gati</surname><given-names>I</given-names></name><name><surname>Babila</surname><given-names>T</given-names></name><name><surname>Haver</surname><given-names>E</given-names></name><name><surname>Katz</surname><given-names>U</given-names></name></person-group><article-title>Effect of salt acclimation on digitalis-like compounds in the toad</article-title><source>Biochim Biophys Acta</source><year>1991</year><volume>1073</volume><fpage>65</fpage><lpage>68</lpage></citation><citation citation-type="display-unstructured">Lichtstein D, Gati I, Babila T, Haver E, Katz U (1991) Effect of salt acclimation on digitalis-like compounds in the toad. Biochim Biophys Acta 1073:65&#x02013;68 <pub-id pub-id-type="pmid">1991148</pub-id></citation></ref><ref id="CR64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopatin</surname><given-names>DA</given-names></name><name><surname>Ailamazian</surname><given-names>EK</given-names></name><name><surname>Dmitrieva</surname><given-names>RI</given-names></name><name><surname>Shpen</surname><given-names>VM</given-names></name><name><surname>Fedorova</surname><given-names>OV</given-names></name><name><surname>Doris</surname><given-names>PA</given-names></name><name><surname>Bagrov</surname><given-names>AY</given-names></name></person-group><article-title>Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia</article-title><source>J Hypertens</source><year>1999</year><volume>17</volume><fpage>1179</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1097/00004872-199917080-00018</pub-id></citation><citation citation-type="display-unstructured">Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY (1999) Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17:1179&#x02013;1187 <pub-id pub-id-type="pmid">10466474</pub-id></citation></ref><ref id="CR65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagrov</surname><given-names>AY</given-names></name><name><surname>Fedorova</surname><given-names>OV</given-names></name><name><surname>Dmitrieva</surname><given-names>RI</given-names></name><name><surname>French</surname><given-names>AW</given-names></name><name><surname>Anderson</surname><given-names>DE</given-names></name></person-group><article-title>Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs</article-title><source>Cardiovasc Res</source><year>1996</year><volume>31</volume><fpage>296</fpage><lpage>305</lpage></citation><citation citation-type="display-unstructured">Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE (1996) Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. Cardiovasc Res 31:296&#x02013;305 <pub-id pub-id-type="pmid">8730407</pub-id></citation></ref><ref id="CR66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonick</surname><given-names>HC</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Vaziri</surname><given-names>ND</given-names></name><name><surname>Bagrov</surname><given-names>AY</given-names></name><name><surname>Fedorova</surname><given-names>OV</given-names></name></person-group><article-title>Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states</article-title><source>Clin Exp Hypertens</source><year>1998</year><volume>20</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.3109/10641969809053240</pub-id></citation><citation citation-type="display-unstructured">Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV (1998) Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens 20:617&#x02013;627 <pub-id pub-id-type="pmid">9682918</pub-id></citation></ref><ref id="CR67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aperia</surname><given-names>A</given-names></name></person-group><article-title>New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target</article-title><source>J Intern Med</source><year>2007</year><volume>261</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2006.01745.x</pub-id></citation><citation citation-type="display-unstructured">Aperia A (2007) New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med 261:44&#x02013;52 <pub-id pub-id-type="pmid">17222167</pub-id></citation></ref><ref id="CR68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zelenin</surname><given-names>S</given-names></name><name><surname>Aperia</surname><given-names>A</given-names></name><name><surname>Aizman</surname><given-names>O</given-names></name></person-group><article-title>Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB</article-title><source>J Am Soc Nephrol</source><year>2006</year><volume>17</volume><fpage>1848</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1681/ASN.2005080894</pub-id></citation><citation citation-type="display-unstructured">Li J, Zelenin S, Aperia A, Aizman O (2006) Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol 17:1848&#x02013;1857 <pub-id pub-id-type="pmid">16707566</pub-id></citation></ref><ref id="CR69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>P</given-names></name><name><surname>Ferrandi</surname><given-names>M</given-names></name><name><surname>Valentini</surname><given-names>G</given-names></name><name><surname>Manunta</surname><given-names>P</given-names></name><name><surname>Bianchi</surname><given-names>G</given-names></name></person-group><article-title>Targeting ouabain- and adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach</article-title><source>Med Hypotheses</source><year>2007</year><volume>68</volume><fpage>1307</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2006.07.058</pub-id></citation><citation citation-type="display-unstructured">Ferrari P, Ferrandi M, Valentini G, Manunta P, Bianchi G (2007) Targeting ouabain- and adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Med Hypotheses 68:1307&#x02013;1314 <pub-id pub-id-type="pmid">17097240</pub-id></citation></ref><ref id="CR70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>DJ</given-names></name><name><surname>Vetteth</surname><given-names>S</given-names></name><name><surname>Periyasamy</surname><given-names>SM</given-names></name><name><surname>Kanj</surname><given-names>M</given-names></name><name><surname>Fedorova</surname><given-names>L</given-names></name><name><surname>Khouri</surname><given-names>S</given-names></name><name><surname>Kahaleh</surname><given-names>MB</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Malhotra</surname><given-names>D</given-names></name><name><surname>Kolodkin</surname><given-names>NI</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Fedorova</surname><given-names>OV</given-names></name><name><surname>Bagrov</surname><given-names>AY</given-names></name><name><surname>Shapiro</surname><given-names>JI</given-names></name></person-group><article-title>Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy</article-title><source>Hypertension</source><year>2006</year><volume>47</volume><fpage>488</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000202594.82271.92</pub-id></citation><citation citation-type="display-unstructured">Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI (2006) Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47:488&#x02013;495 <pub-id pub-id-type="pmid">16446397</pub-id></citation></ref><ref id="CR71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stella</surname><given-names>P</given-names></name><name><surname>Manunta</surname><given-names>P</given-names></name><name><surname>Mallamaci</surname><given-names>F</given-names></name><name><surname>Melandri</surname><given-names>M</given-names></name><name><surname>Spotti</surname><given-names>D</given-names></name><name><surname>Tripepi</surname><given-names>G</given-names></name><name><surname>Hamlyn</surname><given-names>JM</given-names></name><name><surname>Malatino</surname><given-names>LS</given-names></name><name><surname>Bianchi</surname><given-names>G</given-names></name><name><surname>Zoccali</surname><given-names>C</given-names></name></person-group><article-title>Endogenous ouabain and cardiomyopathy in dialysis patients</article-title><source>J Intern Med</source><year>2008</year><volume>263</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2007.01883.x</pub-id></citation><citation citation-type="display-unstructured">Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G, Hamlyn JM, Malatino LS, Bianchi G, Zoccali C (2008) Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 263:274&#x02013;280 <pub-id pub-id-type="pmid">18070001</pub-id></citation></ref></ref-list><fn-group><fn><p>&#x0201c;Public Health would benefit more by applying what is known already than from scientific breakthroughs.&#x0201d; Lord Rosenheim (1908&#x02013;1972)</p></fn></fn-group></back></article>